TAG:
Fee-for-service
Fee-for-service has long been the primary payment model for clinical laboratories and pathology groups. Fee-for-service (FFS) is a payment model in which services are paid for as itemized in the provider’s invoice. It gives an incentive for physicians to provide more treatments because payment is dependent on the quantity of care, rather than quality of care. Similarly, patients are incentivized to welcome any medical service that might not be necessary. Insurance companies shield themselves against ruin by setting cover limits for every beneficiary.
FFS raises costs, discourages the efficiencies of integrated care, and a variety of reform efforts have been attempted, recommended, or initiated to reduce its influence (such as moving towards bundled payments and capitation).
Medicare Parts A (hospital insurance) and B (optional insurance that covers physician, outpatient hospital, home health, laboratory tests, durable medical equipment, designated therapy, outpatient prescription drugs, and other services not covered by Part A) are FFS programs. Medicare processes over one billion FFS claims per year.
As part of the ongoing drive to cut healthcare costs, this model is gradually being phased out by payers and healthcare organizations in favor of value-based payment models, such as pay-for-performance programs and accountable care organizations that are intended to cap costs and spread financial risk among providers, while encouraging coordination of care, disease prevention and better management of chronic conditions. This is seen as a threat to the survival of clinical labs, which expect to see far fewer tests ordered by healthcare providers.
The Clinical Laboratory Management Association is working to help labs navigate these changes. “As fee-for-service reimbursement gives way to bundled reimbursement and per-member-per-month payment, labs will only be successful if they add value to physicians by helping them diagnose disease earlier and more accurately,” says CLMA President Paul Epner.
CLMA has named this program “Increasing Clinical Effectiveness,” or ICE. THE DARK REPORT is one of CLMA’s partners in this effort.
“Our hope is that ICE is a catalyst that helps lab administrators, pathologists, and medical laboratory scientists broaden the focus of their laboratory beyond operational efficiency to include measurable impact on positive patient outcomes,” says Epner.
Pathology PPMs Unlike Most Other PPM Firms
PHYSICIAN PRACTICE MANAGEMENT (PPM) companies have arrived at pathology’s doorstep. For better or worse, a new era is pushing its way into the pathology profession. In the first installment of this exclusive DARK REPORT series, we exposed the rotten secret behind the …
Curse Of Consolidation Plagues Health Providers
WITHOUT QUESTION, today’s healthcare world is dominated by a single obvious trend: consolidation. The consequences of consolidation affect every segment of healthcare in the United States. The commercial laboratory industry had the dubious distinction of being the first major segment of healthcare…
“September 28, 1998 Intelligence: Late Breaking Lab News”
Just days ago, Bayer AG announced one of the largest drug-discovery alliances ever created. Bayer will pay Millennium Pharmaceuticals, Inc. $465 million. In return, over a six-year period, Millennium will use genomics techniques to identify cures for various diseases…
Pathologists, Clin Labs, Pharmacogenomics & PPMs
AT MY AGE, I AM LEARNING THAT PEOPLE TEND TO HOLD ONE OF TWO OPINIONS about me. It seems that I can frequently be considered a doddering old fool who is totally unhip (although I recall an even earlier generation calling it “unhep”). On the other hand, there are those who grant me great respect. …
United Health’s Big Losses Derail Merger With Humana
CEO SUMMARY: Considered the darling of the managed care industry by investors, United Healthcare’s huge write-down makes it the latest healthcare behemoth to post an immense loss. Laboratory executives should see this as a sign that even big healthcare companies are struggling to develop fiscal sta…
Expect ISO 9000 To Alter Clinical Lab Management
CEO SUMMARY: Perceptive laboratory executives and pathologists should welcome the impending arrival of ISO 9000 into the clinical laboratory industry. It promises to solve many problems of laboratory management. The diagnostics industry, responsible for manufacturing instruments and suppl…
Executive War College Goes International
IT MAY SURPRISE MANY PEOPLE TO LEARN THAT THIS YEAR’S Executive War College in New Orleans attracted registrants from New Zealand and Germany. What may be even more surprising is the reason they traveled from overseas to come to this particular program. Our editor met with them and learne…
Substance Abuse Testing Gains Increasing Favor
CEO SUMMARY: Here’s an update to our earlier predictions that clinical laboratories would find substance abuse testing to be a profitable adjunct to clinical testing. Evidence accumulates that competition in the drugs of abuse marketplace is intensifying. While still a relatively small …
Unilab & LabOne Demonstrate Improved Revenues and Profits
AFTER AN EXTENDED MULTI-YEAR financial siege, Unilab Corporation seems to be regaining its balance. First quarter financials demonstrate respectable gains in revenue and net income at the California based laboratory. Big gains were posted by LabOne, Inc. of Lenexa, …
A Fable For Our Times: Lab Industry’s Golden Era
CEO SUMMARY: The clinical laboratory industry’s “Golden Era” is gone forever. Replacing it is a healthcare environment best described as “Darwinian.” It is now survival of the fittest, as hospital laboratories and commercial laboratories struggle to reinvent themselves. Case stu…
CURRENT ISSUE
Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.